Lv5
865 积分 2025-09-08 加入
Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders
14天前
已完结
Comprehensive Evaluation of Machine Learning Models and Gene Expression Signatures for Prostate Cancer Prognosis Using Large Population Cohorts
1个月前
已完结
Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells
1个月前
已完结
Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Response
1个月前
已完结
Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer
1个月前
已完结
Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma
1个月前
已完结
Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Response
1个月前
已完结
Autologous HER2 CMV bispecific CAR T cells for progressive glioblastoma: results from a phase I clinical trial
1个月前
已完结
A phase I study of anti-GPC3 chimeric antigen receptor modified T cells (GPC3 CAR-T) in Chinese patients with refractory or relapsed GPC3+ hepatocellular carcinoma (r/r GPC3+ HCC)
1个月前
已关闭
Expansion of HER2-CAR T cells after lymphodepletion and clinical responses in patients with advanced sarcoma
1个月前
已关闭
皖公网安备34019202002308
